ABIVAX SA00370M103US00370M103605/11/2026Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items.SECTION 14A SAY-ON-PAY VOTESISSUER00 ABIVAX SA00370M103US00370M103605/11/2026Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda items.SECTION 14A SAY-ON-PAY VOTESISSUER00 AMAZON.COM, INC.023135106US023135106705/20/2026ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATIONSECTION 14A SAY-ON-PAY VOTESISSUER153020FOR15302FOR APPLIED MATERIALS, INC.038222105US038222105103/12/2026Approval, on an advisory basis, of the compensation of Applied Materials' named executive officers for fiscal year 2025.SECTION 14A SAY-ON-PAY VOTESISSUER54500FOR5450FOR AXOGEN, INC.05463X106US05463X106306/23/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER564750FOR56475FOR BRIDGEBIO PHARMA, INC.10806X102US10806X102806/22/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER1480FOR148FOR BRIDGEBIO PHARMA, INC.10806X102US10806X102806/22/2026To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER14801 YEAR148FOR BWX TECHNOLOGIES, INC.05605H100US05605H100504/30/2026Advisory vote on compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER449920FOR44992FOR CIENA CORPORATION171779309US171779309503/26/2026Advisory vote on our named executive officer compensation, as described in the proxy materials.SECTION 14A SAY-ON-PAY VOTESISSUER33820FOR3382FOR CLOUDFLARE, INC.18915M107US18915M107106/30/2026Approval, on an advisory basis, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER48310FOR4831FOR COGENT BIOSCIENCES, INC.19240Q201US19240Q201206/09/2026Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER13690FOR1369FOR CURTISS-WRIGHT CORPORATION231561101US231561101005/07/2026An advisory (non-binding) vote to approve the compensation of the Company's named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER8340FOR834FOR DBV TECHNOLOGIES S.A.23306J309US23306J309506/03/2026Advisory opinion on the compensation of named executive officers other than the Chief Executive OfficerSECTION 14A SAY-ON-PAY VOTESISSUER00 ELI LILLY AND COMPANY532457108US532457108305/04/2026Approval, on an advisory basis, of the compensation paid to the company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER51890FOR5189FOR FERGUSON ENTERPRISES INC.31488V107US31488V107012/03/2025To approve, on an advisory basis, the fiscal 2025 compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER21080FOR2108FOR FERGUSON ENTERPRISES INC.31488V107US31488V107004/30/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers for the five-month transition period from August 1, 2025 to December 31, 2025.SECTION 14A SAY-ON-PAY VOTESISSUER101450FOR10145FOR FIVE BELOW, INC.33829M101US33829M101806/16/2026To approve, by non-binding advisory vote, the Company's Named Executive Officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER155820FOR15582FOR GE AEROSPACE369604301US369604301305/05/2026Advisory Approval of Our Named Executives' CompensationSECTION 14A SAY-ON-PAY VOTESISSUER124070FOR12407FOR HEICO CORPORATION422806109US422806109303/13/2026ADVISORY APPROVAL OF THE COMPANY'S EXECUTIVE COMPENSATIONSECTION 14A SAY-ON-PAY VOTESISSUER4790FOR479FOR HUT 8 CORP.44812J104US44812J104306/11/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER44520FOR4452FOR INTUITIVE SURGICAL, INC.46120E602US46120E602304/30/2026To approve, by advisory vote, the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER78250FOR7825FOR KRYSTAL BIOTECH, INC.501147102US501147102705/15/2026Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.SECTION 14A SAY-ON-PAY VOTESISSUER2320FOR232FOR MASTEC, INC.576323109US576323109005/21/2026Approval of a non-binding advisory resolution regarding the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8660FOR866FOR MERCADOLIBRE, INC.58733R102US58733R102306/09/2026To approve, on an advisory basis, the compensation of our named executive officers for fiscal year 2025.SECTION 14A SAY-ON-PAY VOTESISSUER3200FOR320FOR META PLATFORMS, INC.30303M102US30303M102705/27/2026A shareholder proposal regarding annual vote regarding executive pay.SECTION 14A SAY-ON-PAY VOTESSECURITY HOLDER4490AGAINST449FOR MICROSOFT CORPORATION594918104US594918104512/05/2025Advisory Vote to Approve Named Executive Officer Compensation (''say-on-pay vote'')SECTION 14A SAY-ON-PAY VOTESISSUER935370FOR93537FOR MKS, INC.55306N104US55306N104605/11/2026The approval, on an advisory basis, of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER96040FOR9604FOR NETFLIX, INC.64110L106US64110L106106/04/2026Advisory approval of named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER159130FOR15913FOR NLIGHT, INC.65487K100US65487K100706/05/2026To approve, on an advisory, non-binding basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER48770FOR4877FOR OXFORD NANOPORE TECHNOLOGIES PLCG6840E103GB00BP6S8Z3006/04/2026APPROVE REMUNERATION REPORTSECTION 14A SAY-ON-PAY VOTESISSUER00 PROTAGONIST THERAPEUTICS, INC.74366E102US74366E102906/17/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7790FOR779FOR QXO, INC.82846H405US82846H405605/05/2026Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER8310FOR831FOR REVOLUTION MEDICINES, INC.76155X100US76155X100006/18/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER88280FOR8828FOR ROCKET LAB CORPORATION773121108US773121108905/20/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers disclosed in the accompanying proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER437520FOR43752FOR ROLLS-ROYCE HOLDINGS PLCG76225104GB00B63H849104/30/2026TO APPROVE THE DIRECTORS REMUNERATION REPORT FOR THE YEAR ENDED 31 DECEMBER 2025SECTION 14A SAY-ON-PAY VOTESISSUER497508128778FOR497508FOR SIEMENS ENERGY AGD6T47E106DE000ENER6Y002/26/2026APPROVE REMUNERATION REPORTSECTION 14A SAY-ON-PAY VOTESISSUER00 SITIME CORPORATION82982T106US82982T106005/29/2026To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER1500FOR150FOR STAAR SURGICAL COMPANY852312305US852312305201/06/2026A proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to STAAR's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.SECTION 14A SAY-ON-PAY VOTESISSUER153240FOR15324FOR TALEN ENERGY CORPORATION87422Q109US87422Q109405/05/2026To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER67250FOR6725FOR TERADYNE, INC.880770102US880770102905/08/2026To approve, on a non-binding, advisory basis, the 2025 compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER70640FOR7064FOR TESLA, INC.88160R101US88160R101411/06/2025A Tesla proposal for a non-binding advisory vote approving 2024 executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER75620FOR7562FOR TEVA PHARMACEUTICAL INDUSTRIES LIMITED881624209US881624209805/28/2026TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION FOR TEVA'S NAMED EXECUTIVE OFFICERSSECTION 14A SAY-ON-PAY VOTESISSUER599990FOR59999FOR THE REALREAL, INC.88339P101US88339P101206/10/2026Approval, on an advisory basis, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER58400FOR5840FOR TTM TECHNOLOGIES, INC.87305R109US87305R109505/07/2026To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER94880FOR9488FOR TTM TECHNOLOGIES, INC.87305R109US87305R109505/07/2026To approve, on an advisory, non-binding basis, the frequency of future advisory votes to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER948801 YEAR9488FOR UNITED THERAPEUTICS CORPORATION91307C102US91307C102706/26/2026Advisory resolution to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER59490FOR5949FOR VERONA PHARMA PLC925050106US925050106409/24/2025To approve, on an advisory, non-binding basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Transaction, as disclosed in the table entitled "Potential Payments to Named Executive Officers" beginning on page 70 of the proxy statement, including the associated narrative discussion, and the agreements or understandings pursuant to which such compensation may be paid or become payable.SECTION 14A SAY-ON-PAY VOTESISSUER934190FOR93419FOR VERTIV HOLDINGS CO92537N108US92537N108106/17/2026To approve, on an advisory basis, the 2025 compensation of our named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER3860590FOR386059FOR WARBY PARKER INC.93403J106US93403J106006/08/2026Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER17630FOR1763FOR